Acute Myeloid Leukemia — Trials

Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,964 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 789
Recruiting: 466
Ph III recruiting: 45
Growth YoY: +3.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (536)

clinicaltrialsPublishedShowing 101–150 of 895 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07813390	Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure(HLA-AML)	enrolling by invitation	Phase 2	73	Guangdong Second Provincial General HospitalOTHER	1	Sep 10, 2026	clinicaltrials
NCT07814339	Hydrochloroquinine & Decitabine With Venetoclax in AML	not yet recruiting	Phase 1	18	Rutgers, The State University of New JerseyOTHER	0	Sep 10, 2026